• Explore /
  • Poster
  • / ZUMA-2: Phase 2 multicenter study evaluating efficacy of kte-C19 in patients with relapsed/refractory mantle cell lymphoma.

ZUMA-2: Phase 2 multicenter study evaluating efficacy of kte-C19 in patients with relapsed/refractory mantle cell lymphoma.

Abstract Poster

Authors

null

Michael Wang

The University of Texas MD Anderson Cancer Center, Houston, TX

Michael Wang , Frederick Lundry Locke , Javier Munoz , Andre Goy , Houston Eccleston Holmes , Tanya Siddiqi , Ian Flinn , Peter A McSweeney , Patrick Michael Reagan , Brian Thomas Hill , Caron A. Jacobson , David A. Rizzieri , Leonard T. Heffner , Samantha Mary Jaglowski , David Bernard Miklos , Paul Shaughnessy , Sherry Unabia , John M. Rossi , Yizhou Jiang , Rajul K. Jain

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics and Translational Research

Sub Track

Cellular Immunotherapy

Clinical Trial Registration Number

NCT02601313

Citation

J Clin Oncol 36, 2018 (suppl; abstr TPS3102)

DOI

10.1200/JCO.2018.36.15_suppl.TPS3102

Abstract #

TPS3102

Poster Bd #

315b

Abstract Disclosures

Similar Posters

First Author: Olalekan O. Oluwole

First Author: Sattva Swarup Neelapu

First Author: Ian Flinn

First Author: Ian W. Flinn